• Collapse SubdiscussionTekola Moore
Tekola Moore
MondayMay 18 at 10:31am
Manage Discussion Entry Professor and Class,
What leads demonstrate the ST depression?
I found that leads I, II, and V2 to V6 demonstrate ST depression. Acute Coronary Syndrome or ACS is demonstrated on an EKG if S...
• collapse subdiscussiontekola moore tekola moore mondaymay 18 at 1031am manage discussion entry professor and class
what leads demonstrate the st depression i found that leads i
Written for
Chamberlain College Of Nursing
NR 603
All documents for this subject (244)
Seller
Follow
LECTMAGGY
Reviews received
Content preview
NR 603 week 3 responses.
• Collapse SubdiscussionTekola Moore
Tekola Moore
MondayMay 18 at 10:31am
Manage Discussion
Entry Professor and
Class,
What leads demonstrate the ST depression?
I found that leads I, II, and V2 to V6 demonstrate ST depression. Acute
Coronary Syndrome or ACS is demonstrated on an EKG if ST depression is
present in six or more leads.
Is Lorene Hypertensive per ACA 2017 Guidelines? Compare the ACA
guidelines to JNC 8 guidelines and discuss what treatment you recommend
for her BP and why.
Yes, Lorene is hypertensive per the guidelines. Lorene’s elevated blood
pressure of 146/90 places her at stage 2 hypertension based on the
American College of Cardiology (ACC) 2017 guidelines. Essential (primary)
hypertension ICD 10
(I10) would be one of Lorene’s secondary diagnose. The ACC/AHA recently
lowered the definition of hypertension to allow for earlier intervention in
the high blood pressure guidelines because complications can occur at
lower blood pressure numbers (Whelton, Carey & Aronow, 2018). The
ACC/AHA defines normal blood pressure as a systolic blood pressure less
than 120 mmHg and a diastolic blood pressure less than 80 mmHg, stage
1 hypertension is a systolic blood pressure 130- 139 mmHg or a diastolic
blood pressure of 80-89 mmHg, and stage II hypertension as a systolic
blood pressure greater than or equal to 140 or a diastolic blood pressure
greater than or equal to 90 (Whelton, Carey, & Aronow, 2018). The ACC
2017 guidelines differ from the Eight Joint National Commision (JNC 8)
guidelines in the blood pressure classification, as well as blood pressure
goal targets based on age and comorbidities. Regardless of age and
whether the patient has diabetes and/or chronic kidney disease (CKD),
the ACC 2017 guidelines recommend a blood pressure goal of less than
130/90. For patients 60 years and older, JNC 8 guidelines recommend
pharmacologic treatment for blood pressure goal of less than 150/90.
The initial pharmacologic treatment for both guidelines is similar, which
includes thiazide diuretics, angiotensin-converting enzyme inhibitors
(ACEI), angiotensin receptor blockers (ARB), and calcium channel blockers
(CCB) (Armstrong, 2014). The ACC/AHA recommendations are based on a
10-year atherosclerotic cardiovascular disease or ASCVD, risk calculator
of 10-year risk or higher. In the presence of BP >140/90 mmHg, even if
ASCVD risk is <10%, antihypertensive treatment is indicated with a goal
of reaching <130/80 mmHg utilizing a two-drug or fixed dose
combination. The JNC-8 recommends pharmacological treatment to
maintain a goal blood pressure of less than 140/90 if diabetes is present
and recommends for the general population with no history of diabetes or
,NR 603 week 3 responses.
chronic kidney disease that are aged 60 or older initiate pharmacologic
treatment if systolic BP is
,NR 603 week 3 responses.
greater than 150 mmHg or diastolic BP is 90mmHg or higher with a goal
of less than 150/90.
Based off these guidelines and the information that was presented in this
case study including the history of hypertension, metabolic syndrome,
dyslipidemia, her elevated BMI, her current ST changes on EKG, current
blood pressure of 146/90, risk factors of drinking and smoking, and her
current age and ethnicity, I would like to start Lorene back on blood
pressure medication with a goal blood pressure of less than 130/80 per
ACC/AHA guidelines. I would initially encourage lifestyle modifications to
help Lorene lower her blood pressure as well as start her on a
combination antihypertensive therapy of Losartan-Hydrochlorothiazide
50mg/12.5mg once daily. Since Lorene stopped taking her Lisinopril due
to the possibility of developing a cough even though she never developed
the cough then due to this fear and her noncompliance of taking the
medication I chose to start her on an ARB with the less possibility of
developing a dry hacking cough that Lisinopril is known to cause (
Whelton, Carey, & Aronow, 2018).
What is the Primary diagnosis causing Lorene's chest pain? Include ICD 10
codes (no differentials)
My primary diagnosis for Lorene’s chest pain is Acute Coronary Syndrome
or ACS which is associated with Acute Ischemic Heart Disease,
Unspecified with ICD 10 (I24.9). The primary diagnosis of ACS was chosen
based on the patient’s presenting signs and symptoms and a review of
systems which consisted of reports of shortness of breath, nausea,
diaphoresis, and discomfort that radiates up and down her shoulder
blades that occurs with exertion and resolves with rest. ACS symptoms
consist of chest pain or discomfort, nausea, diaphoresis or sweating,
feeling of lightheadedness or dizziness, pain or discomfort of arms, back,
neck, jaw or stomach. Since Lorene states she experienced some of these
symptoms initially while at the gym and has felt weak ever since along
with current ST segment changes with depression in six leads or more
further supports the diagnosis of acute coronary syndrome.
What other secondary diagnoses does Lorene have that should be
addressed? (Include the rationale and a reference for your diagnoses)
Essential hypertension (I10). As stated earlier, the ACC and JNC8 guidelines
suggest that Lorene has Stage 2 hypertension due to her blood pressure
of 146/90 mm Hg. Stage 2 hypertension may be diagnosed with blood
pressure reading of greater than or equal to 140/90 (ACC, 2017).
Metabolic syndrome (E88.81). This syndrome is a mixture of various other
disorders. A patient must have three of the five diagnostic criteria to
qualify for this diagnosis. A triglyceride level of 150mgs/dl is one element
needed for this diagnosis. Lorene’s last triglyceride levels were
180mgs/dl., so she is elevated here. A low HDL cholesterol level less than
50 for women indicates metabolic risk and Lorene’s results were 38. Also,
a high blood pressure of 130/85 or higher is also a positive
, NR 603 week 3 responses.
element for Lorene because her readings were 146/90 (National Heart,
Lung, and Blood Institute, 2019).
Prediabetes (R73.03). Lorene’s A1C is 6.4%. According to 2019 diabetes
guidelines she qualifies for this diagnosis. The diagnosis of prediabetes
can be made when the patient has a HgA1C between 5.7 and 6.4%
(American Diabetes Association, 2020).
Impaired fasting glucose (R73.01) In this case study, it is unclear whether
Lorene was previously diagnosed with type 2 DM since she mentioned
having gastrointestinal side effects from Metformin. She also reports only
taking insulin for gestational diabetes with her three pregnancies.
However, based on the lab work from three months ago, Lorene’s
hemoglobin A1c is 6.4%, which places her in the prediabetes category.
Three months ago, her fasting blood glucose was 135 mgs/dl, which is
higher than the normal range (greater than 100 mgs/dl). According to the
American Diabetes Association (ADA, 2020) guidelines, a repeat hg A1c or
a fasting plasma glucose (FPG) and a 2-hour plasma glucose (PG) should
be obtained to confirm a type 2 DM diagnosis. If two different tests (such
as A1C and FPG) are both above the diagnostic threshold, the diagnosis of
type 2 DM is confirmed.
Mixed Hyperlipidemia (E78.2): Mixed hyperlipidemia is another secondary
diagnosis that requires attention during this visitation. Hyperlipidemia,
also referred to as dyslipidemia, is a general term for high levels of lipids
in the plasma (Jellinger et al., 2017). Increased circulating lipids in the
blood vessels build up and create plaque, which narrows the blood
vessels and cause blood blockage (Jellinger et al., 2017). Hyperlipidemia
is most commonly caused by the consumption of foods high in saturated
or trans fats, obesity, smoking, diabetes, and a sedentary lifestyle.
Patients with hyperlipidemia are often asymptomatic until the disorder
progresses to the point where it has caused atherosclerosis. Typically,
patients may have symptoms associated with other problems such as
CAD and hypertension. The most common symptoms include weakness,
fatigue, nausea, and shortness of breath (Jellinger et al., 2017). Lorene
has a history of dyslipidemia, but chose to initiate lifestyle changes
instead of taking hyperlipidemia medications. During this visit, Lorene has
positive pertinent findings within her laboratory results. Her elevated lipid
panel is indicative of hyperlipidemia with total cholesterol 230 mg/dl
(normal is less than 200 mg/dl), LDL 180 mg/dl (normal is less than 100
mg/dl), HDL 38 mg/dl (normal is greater than 40 mg/dl), and triglycerides
180 mg/dl (normal is less than 150 mg/dl).
Obesity, unspecified (E66.9) Obesity is another secondary diagnosis that
requires Lorene’s attention. A healthy body mass index (BMI) is between
18.5 and 24.9 percentile according to the national Heart, Lung, and Blood
Institute. Obesity is considered when the BMI is 33 or above. Lorene is
considered obese due to her BMI being 33.5 (National Heart, Lung, Blood
Institute, 2019).
Design a treatment plan and discuss how each intervention is applicable to
Lorene's case. Consider the following interventions:
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller LECTMAGGY. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $14.84. You're not tied to anything after your purchase.
